287 related articles for article (PubMed ID: 17918360)
1. Identification of Fasciola hepatica recombinant 15-kDa fatty acid-binding protein T-cell epitopes that protect against experimental fascioliasis in rabbits and mice.
Muro A; Casanueva P; López-Abán J; Ramajo V; Martínez-Fernández AR; Hillyer GV
J Parasitol; 2007 Aug; 93(4):817-23. PubMed ID: 17918360
[TBL] [Abstract][Full Text] [Related]
2. Immunoprophylaxis against Fasciola hepatica in rabbits using a recombinant Fh15 fatty acid-binding protein.
Casanueva R; Hillyer GV; Ramajo V; Oleaga A; Espinoza EY; Muro A
J Parasitol; 2001 Jun; 87(3):697-700. PubMed ID: 11426738
[TBL] [Abstract][Full Text] [Related]
3. Adaptive immune stimulation is required to obtain high protection with fatty acid binding protein vaccine candidate against Fasciola hepatica in Balb/C mice.
López-Abán J; Esteban A; Vicente B; Rojas-Caraballo J; del Olmo E; Martínez-Fernández AR; Hillyer GV; Muro A
J Parasitol; 2012 Jun; 98(3):527-35. PubMed ID: 22191522
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD.
Martínez-Fernández AR; Nogal-Ruiz JJ; López-Abán J; Ramajo V; Oleaga A; Manga-González Y; Hillyer GV; Muro A
Vet Parasitol; 2004 Dec; 126(3):287-98. PubMed ID: 15567592
[TBL] [Abstract][Full Text] [Related]
5. Progress in the development of Fasciola hepatica vaccine using recombinant fatty acid binding protein with the adjuvant adaptation system ADAD.
López-Abán J; Casanueva P; Nogal J; Arias M; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Muro A
Vet Parasitol; 2007 Apr; 145(3-4):287-96. PubMed ID: 17275191
[TBL] [Abstract][Full Text] [Related]
6. A novel Fasciola hepatica saposinlike recombinant protein with immunoprophylactic potential.
Espino AM; Hillyer GV
J Parasitol; 2004 Aug; 90(4):876-9. PubMed ID: 15357089
[TBL] [Abstract][Full Text] [Related]
7. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
[TBL] [Abstract][Full Text] [Related]
8. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
[TBL] [Abstract][Full Text] [Related]
9. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
[TBL] [Abstract][Full Text] [Related]
10. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
[TBL] [Abstract][Full Text] [Related]
11. An ultrasensitive capture ELISA for detection of Fasciola hepatica coproantigens in sheep and cattle using a new monoclonal antibody (MM3).
Mezo M; González-Warleta M; Carro C; Ubeira FM
J Parasitol; 2004 Aug; 90(4):845-52. PubMed ID: 15357080
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic activity in Fasciola hepatica is reduced by the administration of cathepsin L mimotopes.
Villa-Mancera A; Quiroz-Romero H; Correa D; Alonso RA
J Helminthol; 2011 Mar; 85(1):51-5. PubMed ID: 20416126
[TBL] [Abstract][Full Text] [Related]
13. Fasciola hepatica: humoral and cytokine responses to a member of the saposin-like protein family following delivery as a DNA vaccine in mice.
Espino AM; Osuna A; Gil R; Hillyer GV
Exp Parasitol; 2005 Aug; 110(4):374-83. PubMed ID: 15907838
[TBL] [Abstract][Full Text] [Related]
14. [Monoclonal antibody mimicking the structure of an immunoprotective epitope against Fasciola hepatica].
Marcet Sánchez R; Figueredo Pino M; Sarracent Pérez J
Rev Cubana Med Trop; 2006; 58(2):154-8. PubMed ID: 23427435
[TBL] [Abstract][Full Text] [Related]
15. The combination of the aliphatic diamine AA0029 in ADAD vaccination system with a recombinant fatty acid binding protein could be a good alternative for the animal schistosomiasis control.
Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Ramajo-Martín V; Muro A
Exp Parasitol; 2015 Jul; 154():134-42. PubMed ID: 25936981
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of sheep against Fasciola hepatica with glutathione S-transferase. Identification and mapping of antibody epitopes on a three-dimensional model of the antigen.
Sexton JL; Wilce MC; Colin T; Wijffels GL; Salvatore L; Feil S; Parker MW; Spithill TW; Morrison CA
J Immunol; 1994 Feb; 152(4):1861-72. PubMed ID: 7509829
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica.
Rivera F; Espino AM
Exp Parasitol; 2016 Jan; 160():31-8. PubMed ID: 26632503
[TBL] [Abstract][Full Text] [Related]
18. Lack of humoral and cellular responses against glutathione S-transferases in Fasciola hepatica experimentally infected sheep.
Moreau E; Chauvin A; Boulard C
Vet Res; 1998; 29(6):585-91. PubMed ID: 9851016
[TBL] [Abstract][Full Text] [Related]
19. A Fasciola hepatica-derived fatty acid binding protein induces protection against schistosomiasis caused by Schistosoma bovis using the adjuvant adaptation (ADAD) vaccination system.
Vicente B; López-Abán J; Rojas-Caraballo J; Pérez del Villar L; Hillyer GV; Martínez-Fernández AR; Muro A
Exp Parasitol; 2014 Oct; 145():145-51. PubMed ID: 25124941
[TBL] [Abstract][Full Text] [Related]
20. A recombinant antigen recognized by Fasciola hepatica-infected hosts.
Silva E; Castro A; Lopes A; Rodrigues A; Dias C; Conceição A; Alonso J; Correia da Costa JM; Bastos M; Parra F; Moradas-Ferreira P; Silva M
J Parasitol; 2004 Aug; 90(4):746-51. PubMed ID: 15357063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
